Skip to Main

Visiting Lecturers

Date Guest Lecturer Home Institution Talk Title
5/22/23 Tom Boike, M.D. MHP Radiation Oncology Institute Innovation makes me happy
5/9/23 Nadia Laack, M.D. Mayo Clinic Metastatic-site directed therapy in pediatric sarcomas: why, when, how
11/21/22 Elizabeth Kidd, M.D. and Thomas Niedermayr, Ph.D. Stanford University Moving the needle: 3D printing and customized tools for gyn interstitial brachytherapy
10/27/22 Shankar Siva, MBBS, Ph.D. Peter MacCallum Cancer Centre Radiotherapy for renal cell carcinoma: renaissance of an overlooked approach
8/12/22 Zhen Tian, Ph.D. University of Chicago Experiences and lessons learned from the development of three R01 research proposals
6/21/22 Roshan Prabhu, M.D., M.Sc.​ Levine Cancer Institute, Atrium Health Preoperative radiosurgery for brain metastases: life is all about timing
5/10/22 Osama Mohamad, M.D., Ph.D.  University of California, San Francisco Deep learning and digital pathology in prostate cancer: the experience from NRG prostate studies
4/11/22 Jimmy J. Caudell, M.D., Ph.D.​ Moffitt Medical Group​ Optimizing the present of H&N radiotherapy and potential paths forward
3/17/22 Amar Kishan, M.D. University of California, Los Angeles Challenging dogma in high-risk prostate cancer: dose and ADT
10/6/21 William A. Hall, M.D. Medical College of Wisconsin Magnetic resonance imaging and radiation therapy, a perfect match
5/28/21 Kavita Dharmarajan, M.D., M.Sc. Department of Radiation Oncology and Brookdale Department of Geriatrics & Palliative Medicine, Mount Sinai Hospital Intro to basic communication skills for any and every interaction
12/3/19 Laura Dawson, M.D. University of Toronto - Princess Margaret Hospital Liver cancer SBRT: ready for prime time?
11/5/19 Christopher R. Loiselle, M.D. TIROG - Swedish Cancer Institute - Radiosurgery Center Cyberknife CNS lecture
8/14/19 Stephen Shiao, M.D., Ph.D. Cedars-Sinai Medical Center Macrophage regulation of the response to radiation
6/12/19 Ranjit Bindra, M.D. Yale School of Medicine Exploiting metabolic vulnerabilities in adult and pediatric CNS tumors: bench to bedside at the speed of Yale science
3/1/19 William Small Jr., M.D. Loyola University Medical Center Radiation's role in endometrial cancer
8/3/18 Walter Curran Jr., M.D. Emory University NRG Oncology: a case study for multi-institutional cancer research
6/20/18 Felix Feng, M.D. University of California San Francisco Understanding the prostate cancer genome: from biomarker discovery to clinical application
3/23/18 Sarah S. Donaldson, M.D. Stanford University School of Medicine Rhabdomyosarcoma - a story in evolution
1/22/18 Joseph M. Herman, M.D. MD Anderson Cancer Center Multidisciplinary management of pancreas cancer: evaluating the role of SBRT in localized and recurrent disease
3/10/17 Quynh-Thu Le, M.D. Stanford University School of Medicine Tackling salivary gland stem cells to improve function after radiotherapy
4/22/16 Karyn Goodman, M.D. University of Colorado Individualizing radiotherapy for colorectal cancer
3/4/16 Reshma Jagsi, M.D. University of Michigan Stewardship and value in oncology: are we choosing wisely in managing breast cancer?
12/1/15 Stephen M. Hahn, M.D., FASTRO MD Anderson Cancer Center Radiation oncology engagement in the era of value-based health care
8/28/15 David R. Grosshans, M.D., Ph.D. MD Anderson Cancer Center Radiation biology and physics in the treatment of brain tumors: neurons and particles
5/14/15 Mylin Torres, M.D. Emory University The epigenetic and morphologic memory of breast cancer treatment‐induced inflammation, fatigue and skin toxicity
4/24/15 Albert Koong, M.D., Ph.D. Stanford University School of Medicine The emerging role of stereotactic ablative radiotherapy (SABR) in the management of pancreatic cancer
4/16/15 Beth Beadle, M.D. MD Anderson Cancer Center Modern techniques for the treatment of head and neck cancer
3/27/15 Richard T. Hoppe, M.D., FACR Stanford University School of Medicine Clinical trials in stage I-II Hodgkin's lymphoma: how we got here and where are we going?
1/16/15 Perry W. Grigsby, M.D. Washington University School of Medicine, St. Louis Imaging in the management of cervical cancer, with focus on MRI and PET
11/13/14 Simon N. Powell, M.D., Ph.D. Memorial Sloan-Kettering Targeting DNA repair as an approach to cancer therapy
4/25/14 David J. Sher, M.D., M.P.H. Rush University Medical Center Cost-effectiveness analysis in radiation oncology: the time is right or that ship has sailed?
3/27/14 Michael J. Zelefsky, M.D. Memorial Sloan-Kettering Optimizing the outcomes for high-risk prostate cancer with radiotherapy: can we do better?
2/28/14 Maria Werner-Wasik, M.D. Thomas Jefferson University Preoperative treatment for lung cancer + pancoast tumor
4/26/13 Jay R. Harris, M.D. Harvard Medical School Update on the local treatment of breast cancer
3/29/13 Lisa Kachnic, M.D. Boston Medical Center Optimizing sphincter preservation and minimizing treatment-related toxicity in anal cancer
2/8/13 Arnold de la Cruz Paulino, M.D. The Methodist Hospital Research Institute Late effects of radiotherapy in childhood cancer
1/18/13 William M. Mendenhall, M.D. University of Florida The recent advances in head and neck cancer
5/18/12 Suzanne L. Wolden, M.D. Memorial Sloan-Kettering Pediatric sarcomas
4/27/12 David Raben, M.D. University of Colorado Where is the science and clinical data leading us in the management of locally advanced head and neck cancer in 2012?
3/23/12 Abram Recht, M.D. Beth Israel Deaconess Medical Center Management of the regional nodes in the era of sentinel node
2/24/12 Joel E. Tepper, M.D. University of North Carolina, Chapel Hill The changing landscape in the management of rectal cancer
1/27/12 Arno J. Mundt, M.D. University of California, San Diego Gynecologic IMRT: past, present and future
11/18/11 Andrea K. Ng, M.D., M.P.H. Harvard Medical School Role of radiation therapy in aggressive Non-Hodgkin's lymphoma: indications and optimal timing, field and dose
6/10/11 Akila Viswanathan, M.D. Harvard Medical School Advances in image-guided therapy for cervical cancer
5/13/11 Robert S. Lavey, M.D., Ph.D. Moffit Cancer Center & Research Institute Treatment of CNS germinoma
4/29/11 Peter Grimm, D.O. Prostate Cancer Treatment Center, Seattle Brachytherapy role in the treatment of prostate cancer
1/28/11 Avraham Eisbruch, M.D. University of Michigan The evolution of and current evidence that supports the use of IMRT in head and neck cancer
9/21/10 Bruce Haffty, M.D. University of Medicine & Dentistry of New Jersey, Robert Wood Johnson University Hospital Post-mastectomy and radiation therapy
4/9/10 Joachim Yahalom, M.D., FACR Memorial Sloan-Kettering Hodgkin's lymphoma: increasing cure and with modern radiation therapy
3/19/10 Nancy Y. Lee, M.D. Memorial Sloan-Kettering IMRT for head and neck cancer: past, present, future
2/19/10 Howard M. Sandler, M.D. Cedars-Sinai Medical Center Post-prostatectomy radiation
1/29/10 Larry E. Kun, M.D. St. Jude Children's Research Hospital Radiation therapy for CNS tumors in children - role in multidisciplinary translational therapy
9/25/09 Barbara Fowble, M.D. University of California, San Francisco Age as a defining factor in the role of radiation for breast cancer
5/1/09 David Gaffney, M.D., Ph.D. University of Utah Gynecologic radiation oncology: promises and perils
3/27/09 Thomas F. Delaney, M.S. Harvard Medical School, Massachusetts General Hospital Important clinical issues in charged particle radiotherapy
2/13/09 Minesh P. Mehta, M.D. University of Wisconsin, Madison Management of anaplastic gliomas
1/23/09 Chi Lin, M.D., Ph.D. University of Nebraska, Omaha Radiation therapy for stage II and III rectal cancer
12/4/08 Anthony L. Zietman, M.D. Harvard Medical School Prostate cancer: proton beams, proton dreams and proton schemes
11/7/08 Wade L. Thorstad, M.D. Washington University School of Medicine, St. Louis Evolution of IMRT for head and neck cancer
2/29/08 Eli Glatstein, M.D. University of Pennsylvania Lymphoma
2/13/08 Peter Mauch, M.D. Harvard Medical School Early stage Hodgkin's disease: strategies to improve survival and reduce late treatment-related complications
1/25/08 Shiao Y. Woo, M.D. MD Anderson Cancer Center Proton therapy
1/10/08 Anthony V. D'Amico, M.D., Ph.D. Harvard Medical School Prostate cancer update 2007
10/12/07 Robert J. Amdur, M.D. University of Florida Health Science Center Thyroid cancer management
9/21/07 Lori Pierce, M.D. University of Michigan Breast conserving surgery and radiotherapy in BRCA 1/2 associated breast cancer
5/11/07 Chul S. Ha, M.D. University of Texas Medical School at San Antonio PET, CT and PCR: how do they affect medical decision for patients with lymphoma?
3/23/07 Ritsuko Komaki, M.D., FACR MD Anderson Cancer Center Controversies in the management of limited small cell lung cancer 
12/13/06 Clifford Chao, M.D. MD Anderson Cancer Center Challenges and opportunities in image-guided therapy
11/22/06 Jeffrey A. Cadeddu, M.D. UT Southwestern Medical Center Minimally invasive prostatectomy techniques
11/15/06 Christopher H. Crane, M.D. MD Anderson Cancer Center Chemoradiation in localized pancreatic cancer
10/6/06 David I. Rosenthal, M.D. MD Anderson Cancer Center The evolving role of targeted therapy: focus on head and neck cancer